The Justice Department is continuing to use criminal enforcement as an important tool in the fight against healthcare fraud. While the False Claims Act continues its important place in.
According to prosecutors, the individuals ran a scheme in which marketers targeted federal health care program beneficiaries for unnecessary genetic testing.
The owner and CEO of Crestar Labs, LLC was charged Friday with aiding and abetting a Medicare billing scheme centered around genetic testing in cancer patients.